However the team from the Krebs Institute for Nucleic Acids at the University of Sheffield found that the key to preventing resistance to a common class of chemotherapy used to treat breast and colon cancer is to change the speed in which
the cancer cells repair damage to their DNA that is introduced by chemotherapy.
Not exact matches
Its drug Niraparib kills
cancer cells by inhibiting the production of proteins called PARPs, which help
repair damaged DNA strands, thereby hastening the death of some types of
cancer cells.
This makes me happy: Microglia
cells migrate into tumors and supply
cancer cells with a substance needed for the
repair of DNA damage.
Duly reverential, the panel satisfied itself with simply listing all the research possibilities, including the improvement and increased safety of IVF, the creation of
cell lines that might someday be useful for bone marrow transplantation,
repair of spinal cord injuries, skin replacement and, naturally, the hint of a greater understanding of
cancer.»
The body wears out, mutations accumulate faster than can be
repaired just through the natural process of
cell division,
cancer grows, arthritis wracks the world worn joints, the child born with tetralogy of Fallot away from surgical care dies.
PARP inhibitors prevent DNA
repair causing
cancer cells to die rather than
repair.
A type of immune therapy known as PD - 1 blockade controlled
cancer in 77 percent of patients with defects in DNA mismatch
repair — the system
cells use to spell - check and fix errors in DNA (SN Online: 10/7/15).
The study found that carfilzomib and irinotecan have a potential synergistic effect in SCLC and other Irinotecan - sensitive
cancers by allowing normal DNA damage
repair and enabling normal
cell - cycle death.
Certain kinds of
cancer cells depend heavily on PARP to
repair DNA damage.
«For this reason, we decided to combine vitamin C with a PARP inhibitor, a drug type known to cause
cancer cell death by blocking the
repair of DNA damage, and already approved for treating certain patients with ovarian
cancer.»
PARP inhibitors target and block proteins which
cancer cells depend on to
repair DNA for their survival.
This leads to massive DNA damage that can not be
repaired, and the
cancer cells self - destruct.
Taken together, these findings suggest that BRCA2 mutations increase susceptibility to breast
cancer by disrupting DNA
repair and allowing
cells to accumulate mutations, including those that foster
cancer development.
Once stem
cells can be grown and differentiated in a controlled way to replace degenerated
cells and
repair tissues, medical science may then be able to diagnose and cure many intractable diseases at their earliest stages, such as type 1 diabetes, Parkinson's disease, various cardiovascular diseases, liver disease, and
cancer.
Now, results described in tomorrow's issue of Nature suggest that BRCA2 mutations could lead to
cancer by interfering with
cells» ability to
repair damaged DNA.
Synthetic biocircuits made of DNA and encoded proteins could be inserted to detect and
repair (or kill)
cells with mutations known to cause
cancer or aging.
PARP inhibitors prevent
cancer cells from
repairing themselves after experiencing DNA damage (for example from chemotherapy or radiation).
Olaparib is good at killing
cancer cells that have errors in genes that have a role in
repairing damaged DNA such as BRCA1 or BRCA2.
«If the main DNA
repair pathway, BRCA - mediated homologous recombination, becomes defective,
cancer cells adapt and still proliferate.»
But scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) now think they can help overcome that problem, thanks to their discovery of a small molecule that selectively kills BRCA - deficient
cancer cells by blocking the activity of an alternative DNA
repair pathway.
Rad3 signalling ensures that
cells do not divide before DNA damages are
repaired and thus provides
cancer cells with a mechanism to resist chemotherapy by
repairing these DNA damages.
They found that
cancer cells had acquired new genetic changes that cancelled out the original errors in DNA
repair — particularly in the genes BRCA2 and PALB2 — that had made the
cancer susceptible to olaparib in the first place.
«DNA
repair helps thwart
cancer and keep the
cell in top shape — it is usually all in a day's work within each
cell,» Dr. Durocher adds.
If the DNA is not
repaired,
cells may begin growing uncontrollably, leading to the development of
cancer.
Our body has a system to
repair DNA damage (DNA
repair mechanism), so why a normal
cell turns into a
cancer cell and why radiation exposure causes
cancer have not been clarified.
Significantly, treatment with 6AN specifically decreased the activity of genes with malignant,
cancer - spreading functions, like
cell cycle control and DNA
repair.
In previous research, this team of University of Alberta researchers found that PRC1 complex helps to
repair DNA damage in
cancer cells.
«
Cancer cells that resist therapy are able to
repair themselves despite the DNA damage.
Importantly, like
cancer cells with other mutations in the HR
repair pathway, CHD1 - depleted prostate
cancer cells proved to be hypersensitive to chemotherapeutic drugs causing DNA breaks, such as Mitomycin C, Irinotecan and PARP inhibitors.
Their findings in the study «Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination
repair in
cancer cells,» which has been published in The Journal of
Cell Biology, suggest that this FDA - approved ovarian
cancer medicine has the potential to treat a wider range of
cancer types than currently indicated.
In particular, it has been shown that
cells with other HR
repair pathway defects, such as BRCA mutations frequently found in breast and ovarian
cancer, are sensitive to inhibition of the enzyme PARP, and the PARP inhibitor Olaparib has been approved for treatment of BRCA - mutated ovarian
cancers.
Dr Gillian Farnie, whose work at the University's Institute of
Cancer Sciences was funded by a five - year # 500,000 Breast Cancer Campaign Scientific Fellowship, said: «We know that cancer stem cells are able to avoid or repair damage caused by trea
Cancer Sciences was funded by a five - year # 500,000 Breast
Cancer Campaign Scientific Fellowship, said: «We know that cancer stem cells are able to avoid or repair damage caused by trea
Cancer Campaign Scientific Fellowship, said: «We know that
cancer stem cells are able to avoid or repair damage caused by trea
cancer stem
cells are able to avoid or
repair damage caused by treatment.
It is known that
cells without this type of DNA
repair can develop mutations leading to
cancer development.
So if biologists can discover how to disable
cancer cells» DNA
repair proteins, it may be possible to destroy tumours using lower doses of radiation or drugs.
Moreover, in some cases, pancreatic
cancer cells can even
repair damage to their DNA caused by the chemotherapy drugs that do get into the tumor, further protecting themselves.
Now his lab has found that Set2 is also a major player in DNA
repair, a complicated and crucial process that can lead to the development of
cancer cells if the
repair goes wrong.
This may be more effective of an approach to
cancer prevention than trying to stop a mutated
cell from dividing and not being able to completely
repair itself.»
They work particularly well if the
cancer cells they attack already have defects in the corresponding DNA
repair pathways, as it frequently occurs in breast
cancer and other tumors.
And researchers at the «Seattle project», an effort funded by the National
Cancer Institute to find new anticancer drugs, are mutating genes in yeast cells — such as the ATM gene or the mismatch repair genes — that often lead to cancer in h
Cancer Institute to find new anticancer drugs, are mutating genes in yeast
cells — such as the ATM gene or the mismatch
repair genes — that often lead to
cancer in h
cancer in humans.
To date, yeast has taught scientists a lot about
cell division and DNA
repair, processes that go wrong in
cancer.
The team at Barts
Cancer Institute, part of Queen Mary University of London, have found that a molecule, called focal adhesion kinase (FAK), signals the body to repair itself after chemotherapy or radiotherapy, which kill cancer cells by damagin
Cancer Institute, part of Queen Mary University of London, have found that a molecule, called focal adhesion kinase (FAK), signals the body to
repair itself after chemotherapy or radiotherapy, which kill
cancer cells by damagin
cancer cells by damaging DNA.
When normal, EMSY, BRCA1 and BRCA2 give the body's
cells instructions to create proteins that help to
repair DNA damage that can cause
cancer.
In normal
cells, this is a part of the wound
repair process when PGE2 induces tissues stem
cells to regrow; in
cancer PGE2 ironically induces regrowth of more
cancer stem
cells in between chemotherapy cycles, Kurtova and Xiao said.
The ERK pathway plays a critical role in embryonic development and tissue
repair because it instructs
cells to multiply and start dividing, but when over activated
cancer growth occurs.
Last week, Lin Zhang, MD, an associate professor of Obstetrics and Gynecology, described in Science Translational Medicine, how his team treated therapy resistant
cancer cells to renew their sensitivity to PARP inhibitors, a class of drugs that, when effective, prevent
cancer cells from keeping up with DNA
repair, causing them to eventually die.
The BET - PARP inhibitor combo represses DNA
repair, allowing PARP inhibitor - induced DNA damage to take over and kill
cancer cells once again.
The stem
cells that proliferate the most in response to damage caused by cigarette smoke
repair their DNA using a process prone to errors, setting the stage for lung
cancer, according to a study publishing January 26, 2017 in the open - access journal PLOS Biology by Marie - Liesse Asselin - Labat and her team of the Walter and Eliza hall Institute of Medical Research, Australia.
In a new study, Yale
Cancer Center researchers identified a novel genetic defect that prevents brain tumor
cells from
repairing damaged DNA.
A report in the 15 February issue of the Proceedings of the National Academy of Sciences suggests that a lotion containing an algal protein can ward off sunburns — often the first step on the road to skin
cancer — by
repairing part of the damage to skin
cells» chromosomes.
The promising results of this experimental study are based on a combination of the drug temozolomid and other extant drugs that inhibit an enzyme instrumental in DNA
repair in
cancer cells.